Macclesfield, United Kingdom

Jonas Malmström


 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Sodertalje, SE (2013)
  • Macclesfield, GB (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jonas Malmström

Introduction

Jonas Malmström is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cognitive disorders. With a total of two patents to his name, Malmström's work reflects a commitment to advancing medical science.

Latest Patents

Malmström's latest patents include the 2-carboxamide-4-piperazinyl-benzofuran derivative. This invention relates to a compound of formula (I), which is utilized in pharmaceutical compositions for therapeutic purposes, especially in treating cognitive disorders. Additionally, he holds a patent for 2-carboxamide-7-piperazinyl-benzofuran derivatives, which also involves compounds of formula (I) and introduces new intermediates useful in their preparation.

Career Highlights

Throughout his career, Malmström has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Acturum Life Science AB. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic applications.

Collaborations

Malmström has collaborated with several professionals in his field, including Helena Gybäck and Johan Andersson. These partnerships have likely enhanced the scope and impact of his inventions.

Conclusion

Jonas Malmström's innovative work in pharmaceuticals demonstrates his dedication to improving cognitive health through his patented compounds. His contributions are valuable to the ongoing development of effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…